Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Assessment of genetic diversity and phylogenetic relationship of Limousin herds in Hungary using microsatellite markers.

Szűcs M, Szabó F, Bán B, Józsa C, Rózsa L, Zsolnai A, Anton I.

Asian-Australas J Anim Sci. 2018 Jul 26. doi: 10.5713/ajas.18.0164. [Epub ahead of print]

2.

Small RNA profiling in Mycobacterium tuberculosis identifies MrsI as necessary for an anticipatory iron sparing response.

Gerrick ER, Barbier T, Chase MR, Xu R, François J, Lin VH, Szucs MJ, Rock JM, Ahmad R, Tjaden B, Livny J, Fortune SM.

Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):6464-6469. doi: 10.1073/pnas.1718003115. Epub 2018 Jun 5.

3.

Harnessing single-cell genomics to improve the physiological fidelity of organoid-derived cell types.

Mead BE, Ordovas-Montanes J, Braun AP, Levy LE, Bhargava P, Szucs MJ, Ammendolia DA, MacMullan MA, Yin X, Hughes TK, Wadsworth MH 2nd, Ahmad R, Rakoff-Nahoum S, Carr SA, Langer R, Collins JJ, Shalek AK, Karp JM.

BMC Biol. 2018 Jun 5;16(1):62. doi: 10.1186/s12915-018-0527-2.

4.

Clinical Results of Mean GTV Dose Optimized Robotic-Guided Stereotactic Body Radiation Therapy for Lung Tumors.

Baumann R, Chan MKH, Pyschny F, Stera S, Malzkuhn B, Wurster S, Huttenlocher S, Szücs M, Imhoff D, Keller C, Balermpas P, Rades D, Rödel C, Dunst J, Hildebrandt G, Blanck O.

Front Oncol. 2018 May 17;8:171. doi: 10.3389/fonc.2018.00171. eCollection 2018.

5.

Anti-apoptotic Protein BIRC5 Maintains Survival of HIV-1-Infected CD4+ T Cells.

Kuo HH, Ahmad R, Lee GQ, Gao C, Chen HR, Ouyang Z, Szucs MJ, Kim D, Tsibris A, Chun TW, Battivelli E, Verdin E, Rosenberg ES, Carr SA, Yu XG, Lichterfeld M.

Immunity. 2018 Jun 19;48(6):1183-1194.e5. doi: 10.1016/j.immuni.2018.04.004. Epub 2018 May 22.

PMID:
29802019
6.

Following-up skin penetration of lidocaine from different vehicles by Raman spectroscopic mapping.

Bakonyi M, Gácsi A, Kovács A, Szűcs MB, Berkó S, Csányi E.

J Pharm Biomed Anal. 2018 May 30;154:1-6. doi: 10.1016/j.jpba.2018.02.056. Epub 2018 Mar 6.

PMID:
29524770
7.

How disease extent can be included in the endoscopic activity index of ulcerative colitis: the panMayo score, a promising scoring system.

Bálint A, Farkas K, Szepes Z, Nagy F, Szűcs M, Tiszlavicz L, Bor R, Milassin Á, Rutka M, Fábián A, Molnár T.

BMC Gastroenterol. 2018 Jan 8;18(1):7. doi: 10.1186/s12876-017-0725-3.

8.

[Experience with cabazitaxel therapy for patients with metastatic castrate resistant prostate cancer in Hungary].

Maráz A, Boér K, Dankovics Z, Dank M, Lahm E, Petrányi Á, Révész J, Ruzsa Á, Szûcs M, Valikovics A, Vas M, Küronya Z.

Magy Onkol. 2017 Dec 18;61(4):353-360. Epub 2017 Nov 30. Hungarian.

9.

Rapid adaptive evolution in novel environments acts as an architect of population range expansion.

Szűcs M, Vahsen ML, Melbourne BA, Hoover C, Weiss-Lehman C, Hufbauer RA.

Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13501-13506. doi: 10.1073/pnas.1712934114. Epub 2017 Nov 28.

10.

Quantitative Proteomic Profiling Reveals Novel Plasmodium falciparum Surface Antigens and Possible Vaccine Candidates.

Nilsson Bark SK, Ahmad R, Dantzler K, Lukens AK, De Niz M, Szucs MJ, Jin X, Cotton J, Hoffmann D, Bric-Furlong E, Oomen R, Parrington M, Milner D, Neafsey DE, Carr SA, Wirth DF, Marti M.

Mol Cell Proteomics. 2018 Jan;17(1):43-60. doi: 10.1074/mcp.RA117.000076. Epub 2017 Nov 21.

PMID:
29162636
11.

[Efficacy of the population-based pilot colorectal screening program. Hungary, Csongrád county, 2015].

Rutka M, Molnár T, Bor R, Farkas K, Fábián A, Győrfi M, Bálint A, Milassin Á, Szűcs M, Tiszlavicz L, Nagy F, Szepes Z.

Orv Hetil. 2017 Oct;158(42):1658-1667. doi: 10.1556/650.2017.30822. Hungarian.

PMID:
29037058
12.

Assessment of the Role of Everolimus Therapy in Patients with Renal Cell Carcinoma Based on Daily Routine and Recent Research Results.

Maráz A, Csejtei A, Kocsis J, Szűcs M, Kahán Z, Bodoky G, Dank M, Mangel L, Révész J, Varga Z, Géczi L.

Pathol Oncol Res. 2017 Oct 13. doi: 10.1007/s12253-017-0317-0. [Epub ahead of print]

PMID:
29027615
13.

Endoscopic management of complications of self-expandable metal stents for treatment of malignant esophageal stenosis and tracheoesophageal fistulas.

Bor R, Fábián A, Bálint A, Farkas K, Szűcs M, Milassin Á, Czakó L, Rutka M, Molnár T, Szepes Z.

Therap Adv Gastroenterol. 2017 Aug;10(8):599-607. doi: 10.1177/1756283X17718408. Epub 2017 Jul 10.

14.

Analysis of risk factors - especially different types of plexitis - for postoperative relapse in Crohn's disease.

Milassin Á, Sejben A, Tiszlavicz L, Reisz Z, Lázár G, Szűcs M, Bor R, Bálint A, Rutka M, Szepes Z, Nagy F, Farkas K, Molnár T.

World J Gastrointest Surg. 2017 Jul 27;9(7):167-173. doi: 10.4240/wjgs.v9.i7.167.

15.

The power of evolutionary rescue is constrained by genetic load.

Stewart GS, Morris MR, Genis AB, Szűcs M, Melbourne BA, Tavener SJ, Hufbauer RA.

Evol Appl. 2017 May 26;10(7):731-741. doi: 10.1111/eva.12489. eCollection 2017 Aug.

16.

The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases.

Penke B, Fulop L, Szucs M, Frecska E.

Curr Neuropharmacol. 2018;16(1):97-116. doi: 10.2174/1570159X15666170529104323. Review.

17.

Pregnancy does not affect fecal calprotectin concentration in healthy women.

Bálint A, Berényi A, Farkas K, Pallagi Kunstár É, Altorjay Á, Csonka A, Krizsán M, Szűcs M, Pál A, Fábián A, Bor R, Milassin Á, Szulcsán Á, Mariann R, Szepes Z, Molnár T.

Turk J Gastroenterol. 2017 May;28(3):171-175. doi: 10.5152/tjg.2017.16711. Epub 2017 Mar 23.

18.

Genetic and demographic founder effects have long-term fitness consequences for colonising populations.

Szűcs M, Melbourne BA, Tuff T, Weiss-Lehman C, Hufbauer RA.

Ecol Lett. 2017 Apr;20(4):436-444. doi: 10.1111/ele.12743. Epub 2017 Feb 1.

PMID:
28145080
19.

Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific Survival.

Niedworok C, Tschirdewahn S, Reis H, Lehmann N, Szücs M, Nyirády P, Romics I, Rübben H, Szarvas T.

Pathol Oncol Res. 2017 Jul;23(3):643-650. doi: 10.1007/s12253-016-0171-5. Epub 2016 Dec 23.

PMID:
28012116
20.

[Factors influencing early detection of malignant melanoma].

Petrovszki I, Csányi I, Szűcs M, Ócsai H, Houshmand N, Kemény L, Oláh J, Baltás E.

Orv Hetil. 2016 Dec;157(51):2028-2033. Hungarian.

PMID:
27989229
21.

Knowledge and attitudes of female university students on menstrual cycle and contraception.

Szűcs M, Bitó T, Csíkos C, Párducz Szöllősi A, Furau C, Blidaru I, Kapamadzija A, Sedlecky K, Bártfai G; Scientific Group of the collaborating centres.

J Obstet Gynaecol. 2017 Feb;37(2):210-214. doi: 10.1080/01443615.2016.1229279. Epub 2016 Dec 6.

PMID:
27923286
22.

Prospective Comparison of Magnetic Resonance Imaging, Transrectal and Transperineal Sonography, and Surgical Findings in Complicated Perianal Crohn Disease.

Bor R, Farkas K, Bálint A, Szűcs M, Ábrahám S, Milassin Á, Rutka M, Nagy F, Milassin P, Szepes Z, Molnár T.

J Ultrasound Med. 2016 Nov;35(11):2367-2372. Epub 2016 Sep 14.

PMID:
27629757
23.

Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the Colorectum.

Rutka M, Bor R, Bálint A, Fábián A, Milassin Á, Nagy F, Szepes Z, Szűcs M, Tiszlavicz L, Farkas K, Molnár T.

Mediators Inflamm. 2016;2016:2492081. doi: 10.1155/2016/2492081. Epub 2016 Jun 16.

24.

Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer.

Szendrői A, Szász AM, Kardos M, Tőkés AM, Idan R, Szűcs M, Kulka J, Nyirády P, Szendrői M, Szállási Z, Győrffy B, Tímár J.

Oncotarget. 2016 Jul 5;7(27):42086-42098. doi: 10.18632/oncotarget.9669.

25.

[Long-term adalimumab therapy in ulcerative colitis in clinical practice: result of the Hungarian multicenter prospective study].

Rutka M, Bálint A, Farkas K, Palatka K, Lakner L, Miheller P, Rácz I, Hegede G, Vincze Á, Horváth G, Szabó A, Nagy F, Szepes Z, Gábor Z, Zsigmond F, Zsóri Á, Juhász M, Csontos Á, Szűcs M, Bor R, Milassin Á, Molnár T.

Orv Hetil. 2016 May 1;157(18):706-11. doi: 10.1556/650.2016.30429. Hungarian.

PMID:
27106726
26.

[Improvement of the reliability of the cause of death diagnoses by co-operation of public health authorities and the Central Statistical Office in Hungary].

Szücs M, Pintérné Grósz D, Sándor J.

Orv Hetil. 2016 Mar 27;157(13):504-11. doi: 10.1556/650.2016.30398. Hungarian.

PMID:
26996898
27.

Trends in Gastrointestinal Cancer Mortality Rate in Hungary.

Farkas K, Szűcs M, Nyári TA.

Pathol Oncol Res. 2016 Oct;22(4):681-8. doi: 10.1007/s12253-016-0052-y. Epub 2016 Mar 10.

PMID:
26965245
28.

A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer.

Annaházi A, Ábrahám S, Farkas K, Rosztóczy A, Inczefi O, Földesi I, Szűcs M, Rutka M, Theodorou V, Eutamene H, Bueno L, Lázár G, Wittmann T, Molnár T, Róka R.

Br J Cancer. 2016 Mar 29;114(7):787-92. doi: 10.1038/bjc.2016.31. Epub 2016 Feb 23.

29.

[Cost-effectiveness trial of self-expandable metal stents and plastic biliary stents in malignant biliary obstruction].

Daróczi T, Bor R, Fábián A, Szabó E, Farkas K, Bálint A, Czakó L, Rutka M, Szűcs M, Milassin Á, Molnár T, Szepes Z.

Orv Hetil. 2016 Feb 14;157(7):268-74. doi: 10.1556/650.2016.30365. Hungarian.

PMID:
26853728
30.

Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method.

Niedworok C, vom Dorp F, Tschirdewahn S, Rübben H, Reis H, Szucs M, Szarvas T.

Int Urol Nephrol. 2016 Mar;48(3):355-61. doi: 10.1007/s11255-015-1185-8. Epub 2016 Jan 2.

PMID:
26725072
31.

Reply to Wootton and Pfister: The search for general context should include synthesis with laboratory model systems.

Hufbauer RA, Szűcs M, Kasyon E, Youngberg C, Koontz MJ, Richards C, Tuff T, Melbourne BA.

Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):E5904. doi: 10.1073/pnas.1517210112. Epub 2015 Oct 19. No abstract available.

32.

Efficacy and Safety of Adalimumab in Ulcerative Colitis Refractory to Conventional Therapy in Routine Clinical Practice.

Bálint A, Farkas K, Palatka K, Lakner L, Miheller P, Rácz I, Hegede G, Vincze Á, Horváth G, Szabó A, Nagy F, Szepes Z, Gábor Z, Zsigmond F, Zsóri Á, Juhász M, Csontos Á, Szűcs M, Bor R, Milassin Á, Rutka M, Molnár T.

J Crohns Colitis. 2016 Jan;10(1):26-30. doi: 10.1093/ecco-jcc/jjv169. Epub 2015 Sep 20.

PMID:
26392413
33.

Three types of rescue can avert extinction in a changing environment.

Hufbauer RA, Szűcs M, Kasyon E, Youngberg C, Koontz MJ, Richards C, Tuff T, Melbourne BA.

Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10557-62. doi: 10.1073/pnas.1504732112. Epub 2015 Aug 3.

34.

Antidepressant drugs and teenage suicide in Hungary: Time trend and seasonality analysis.

Otuyelu E, Foldvari A, Szabo E, Sipos V, Edafiogho P, Szucs M, Dome P, Rihmer Z, Sandor J.

Int J Psychiatry Clin Pract. 2015;19(3):221-5. doi: 10.3109/13651501.2015.1061017. Epub 2015 Jul 7.

PMID:
26058968
35.

[Comparison of symptoms, laboratory parameters and illness perception in patients with irritable bowel syndrome and inflammatory bowel disease].

Bor R, Balanyi Z, Farkas K, Bálint A, Rutka M, Szűcs M, Milassin Á, Szepes Z, Nagy F, Molnár T.

Orv Hetil. 2015 Jun 7;156(23):933-8. doi: 10.1556/650.2015.30168. Hungarian.

PMID:
26027601
36.

Estimation of incidence, prevalence, and age-at-diagnosis of myasthenia gravis among adults by hospital discharge records.

Foldvari A, Kovacs N, Sipos V, Merth G, Vincze F, Szucs M, Sandor J.

Wien Klin Wochenschr. 2015 Jun;127(11-12):459-64. doi: 10.1007/s00508-015-0796-5. Epub 2015 May 20.

PMID:
25990531
37.

Is mucosal healing more common than clinical remission in ulcerative colitis? - Is it the truth or only a myth coming from the studies?

Rutka M, Milassin Á, Szepes Z, SzŰcs M, Nyári T, Bálint A, Bor R, Molnár T, Farkas K.

Scand J Gastroenterol. 2015 Aug;50(8):985-90. doi: 10.3109/00365521.2015.1018313. Epub 2015 Mar 2.

PMID:
25733077
38.

The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases.

Farkas K, Saródi Z, Bálint A, Földesi I, Tiszlavicz L, Szűcs M, Nyári T, Tajti J, Nagy F, Szepes Z, Bor R, Annaházi A, Róka R, Molnár T.

J Crohns Colitis. 2015 Mar;9(3):231-7. doi: 10.1093/ecco-jcc/jjv005. Epub 2015 Jan 12.

PMID:
25585596
39.

Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center.

Bor R, Farkas K, Bálint A, Szucs M, Ábrahám S, Baradnay G, Wittmann T, Szepes Z, Nagy F, Molnár T.

Scand J Gastroenterol. 2015 Feb;50(2):182-7. doi: 10.3109/00365521.2014.936033. Epub 2014 Nov 11.

PMID:
25384713
40.

Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy.

Bálint A, Farkas K, Éva PK, Terhes G, Urbán E, Szucs M, Nyári T, Bata Z, Nagy F, Szepes Z, Miheller P, Lorinczy K, Lakatos PL, Lovász B, Tamás S, Kulcsár A, Berényi A, Törocsik D, Daróczi T, Saródi Z, Wittmann T, Molnár T.

Scand J Gastroenterol. 2015 Feb;50(2):174-81. doi: 10.3109/00365521.2014.928902. Epub 2014 Nov 11.

PMID:
25384624
41.

Faecal matrix metalloprotease-9 is a more sensitive marker for diagnosing pouchitis than faecal calprotectin: results from a pilot study.

Farkas K, Bálint A, Bor R, Földesi I, Szűcs M, Nagy F, Szepes Z, Annaházi A, Róka R, Molnár T.

Expert Rev Gastroenterol Hepatol. 2015 Mar;9(3):387-92. doi: 10.1586/17474124.2015.965144. Epub 2014 Sep 29.

PMID:
25264031
42.

[Clinical efficacy and safety of enzalutamide in metastatic castration-resistant prostate cancer: systematic review and meta-analysis].

Brodszky V, Péntek M, Baji P, Rencz F, Géczi L, Szûcs M, Berczi C, Gulácsi L.

Magy Onkol. 2014 Sep;58(3):189-97. Epub 2014 Aug 2. Review. Hungarian.

43.

The roles of demography and genetics in the early stages of colonization.

Szűcs M, Melbourne BA, Tuff T, Hufbauer RA.

Proc Biol Sci. 2014 Oct 7;281(1792). pii: 20141073. doi: 10.1098/rspb.2014.1073.

44.

Long-term outcome of cyclosporin rescue therapy in acute, steroid-refractory severe ulcerative colitis.

Molnár T, Farkas K, Szepes Z, Nagy F, Szűcs M, Nyári T, Bálint A, Wittmann T.

United European Gastroenterol J. 2014 Apr;2(2):108-12. doi: 10.1177/2050640614520865.

45.

Adequacy of hyaluronan binding assay and a new fertility index derived from it for measuring of male fertility potential and the efficacy of supplement therapy.

Szucs M, Osvath P, Laczko I, Jakab A.

Andrologia. 2015 Jun;47(5):519-24. doi: 10.1111/and.12296. Epub 2014 May 29.

PMID:
24890860
46.

Utility of serum TNF-α, infliximab trough level, and antibody titers in inflammatory bowel disease.

Pallagi-Kunstár É, Farkas K, Szepes Z, Nagy F, Szűcs M, Kui R, Gyulai R, Bálint A, Wittmann T, Molnár T.

World J Gastroenterol. 2014 May 7;20(17):5031-5. doi: 10.3748/wjg.v20.i17.5031.

47.

An archived serum sample as a clue for identifying the primary source of a nosocomial hepatitis C virus outbreak in a haemodialysis unit.

Szücs M, Dencs Á, Varga E, Balajcza BB, Kiss G, Reuter G, Csiky B, Sándor J, Takács M.

Arch Virol. 2014 Sep;159(9):2207-12. doi: 10.1007/s00705-014-2074-7. Epub 2014 Apr 13. Review.

PMID:
24728952
48.

[Experience with everolimus therapy for patients with metastatic renal cancer in Hungary].

Maráz A, Bodoky G, Dank M, Géczi L, Kahán Z, Mangel L, Révész J, Szűcs M.

Magy Onkol. 2014 Mar;58(1):4-9. Epub 2014 Mar 4. Hungarian.

49.

Frequency and prognostic role of mucosal healing in patients with Crohn's disease and ulcerative colitis after one-year of biological therapy.

Farkas K, Lakatos PL, Szűcs M, Pallagi-Kunstár É, Bálint A, Nagy F, Szepes Z, Vass N, Kiss LS, Wittmann T, Molnár T.

World J Gastroenterol. 2014 Mar 21;20(11):2995-3001. doi: 10.3748/wjg.v20.i11.2995.

50.

Do not forget the stool examination!-cutaneous and gastrointestinal manifestations of Blastocystis sp. infection.

Bálint A, Dóczi I, Bereczki L, Gyulai R, Szűcs M, Farkas K, Urbán E, Nagy F, Szepes Z, Wittmann T, Molnár T.

Parasitol Res. 2014 Apr;113(4):1585-90. doi: 10.1007/s00436-014-3805-0. Epub 2014 Feb 20.

PMID:
24553977

Supplemental Content

Support Center